S, P., M, M., P, A., C, G., A, B., R, B., . . . M, R. (2018). 12-month effects of incretins versus SGLT2-Inhibitors on cognitive performance and metabolic profile. A randomized clinical trial in the elderly with Type-2 diabetes mellitus. Dove Medical Press.
Cita Chicago Style (17a ed.)S, Perna, Mainardi M, Astrone P, Gozzer C, Biava A, Bacchio R, Spadaccini D, Solerte SB, y Rondanelli M. 12-month Effects of Incretins Versus SGLT2-Inhibitors on Cognitive Performance and Metabolic Profile. A Randomized Clinical Trial in the Elderly with Type-2 Diabetes Mellitus. Dove Medical Press, 2018.
Cita MLA (8a ed.)S, Perna, et al. 12-month Effects of Incretins Versus SGLT2-Inhibitors on Cognitive Performance and Metabolic Profile. A Randomized Clinical Trial in the Elderly with Type-2 Diabetes Mellitus. Dove Medical Press, 2018.